Posts Tagged ‘nasal’
New agreement allows Nasodine launch in Philippines
15 Aug 2024
Firebrick Pharma is pleased to announce that it has executed an amended agreement with its existing marketing partner in the Philippines, S.V. More Pharma Corporation (SV More). Under the amended agreement, SV More will have the right to manufacture Nasodine® Nasal Spray (“Nasodine”) in the Philippines, rather than import the product from Australia. This will…
Nasodine Phase 3 common cold trial underway
03 May 2022
Firebrick Pharma is pleased to announce that the first patient has been recruited into its confirmatory Phase 3 trial for Nasodine® Nasal Spray (“Nasodine”) as a treatment for the common cold. The randomised controlled Phase 3 trial expects to recruit up to 450 adult subjects with early cold symptoms to achieve a target treatment population…